ClinicalTrials.Veeva

Menu

Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status

Completed

Conditions

Multiple Sclerosis

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02301572
0711009544

Details and patient eligibility

About

Chart review.

Full description

A chart review will be completed on patients with multiple sclerosis to determine potential early characteristics that might be helpful in defining aggressive onset MS and predicting subsequent disease course and disability

Enrollment

750 patients

Sex

All

Ages

Under 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Two or more relapses in the preceding year and 2 or more gadolinium enhancing lesions on brain MRI scan or a significant T 2 lesion burden or
  • One relapse if it results in sustained EDSS of 3.0 along with 2 or more gadolinium enhancing lesions or significant T2 lesion burden ( T2 lesion burden being determined by factoring the number of lesions, the size of the lesions and lesion location)

Exclusion criteria

Trial design

750 participants in 1 patient group

Aggressive onset MS
Description:
Two or more relapses in the preceding year and 2 or more gadolinium enhancing lesions on brain MRI scan or a significant T 2 lesion burden or One relapse if it results in sustained EDSS of 3.0 along with 2 or more gadolinium enhancing lesions or significant T2 lesion burden ( T2 lesion burden being determined by factoring the number of lesions, the size of the lesions and lesion location)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems